NVNO
enVVeno Medical Corp
$11.12
+0.10 (+0.91%)
At close · Jul 8
Market Cap
$7.34M
Shares
667,669
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$11.12
Open$11.70
Day$11.12–11.90
52W$8.67–196.70
Avg vol 30d9K
Short int15K · 2.2% float · 1.9d
Short vol58%
DataJan 2020–Jul 2026
Filing10-Q · May 6
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−23%
below
Price vs 50-day avg
+5%
above
RSI (14)
55
neutral
MACD trend
Positive
52-week position
1%
near low
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+9%
trailing
6-month return
−5%
trailing
YTD return
−1%
this year
Relative strength
−12%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $14 — 200d above 50d
Institutional flow
Accumulating
1 of 17 funds reported for Jun 30 · net +88 sh shares · +1 new
Insider flow
Distributing
Net -$1.4K over 90 days · 100% sells
Short interest
Falling
2.21% of float · ▼ -78.9% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — 13F breadth
Squeeze score
62
elevated · 0–100
Fundamentals
Revenue growth
−83%
Y/Y
Gross margin
597%
expanding
EPS growth
+26%
Y/Y
Free cash flow
$-15.6M
Balance sheet
$3.1M
net cash
Quant / Vol
risk profile
Volatility
120%
annualized · 1-yr
Max drawdown
−95%
past year
ATR
6.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−23%
Bearish
Price vs 50-day avg
+5%
Bullish
RSI (14)
55
Neutral
MACD trend
Positive
Bullish
52-week position
1%
Bearish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $11 › 200d $14 — 200d above 50d
Institutional flow
Accumulating
1 of 17 funds reported for Jun 30 · net +88 sh shares · +1 new
Insider flow
Distributing
Net -$1.4K over 90 days · 100% sells
Short interest
Falling
2.21% of float · ▼ -78.9% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $9
Now $11 · 1%
52-wk high $197
vs 200-day avg -23%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| enVVe valve sizes | 3 | as of April 29, 2026 | — |
| first stage patients | 10 | first stage of the TAVVE study | — |
| second stage control arm patients | 55 | second stage of the study | — |
| second stage patients | 220 | second stage of the study | — |
| second stage patients receiving enVVe valve | 165 | second stage of the study | — |
| U.S. clinical sites | 40 | the TAVVE study | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NVNO
this stock
enVVeno Medical Corp
|
$7.34M | -1.0% | -83.3% | — | 2.2% |
|
ABT
Abbott Laboratories
|
$164.43B | -23.6% | +5.7% | 26.4 | 1.3% |
|
SYK
Stryker Corp
|
$125.40B | -6.8% | +11.2% | 37.9 | 1.6% |
|
MDT
Medtronic plc
|
$105.46B | -13.9% | +8.4% | 22.1 | 1.4% |
|
BSX
Boston Scientific Corp
|
$66.87B | -53.0% | +5.5% | 18.8 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NVNO | +3.8% | +8.9% | -4.9% | +3.8% | -1.0% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +4.0% | +8.1% | -12.3% | +4.0% | -10.3% |